Tough, in-situ thermogelling, injectable hydrogels for biomedical applications

Macromol Biosci. 2015 Apr;15(4):473-80. doi: 10.1002/mabi.201400406. Epub 2015 Jan 3.

Abstract

Injectable hydrogels are extensively used in drug delivery and tissue engineering to administer drugs, genes, growth factors and live cells. We report a method to produce tough, in-situ thermogelling, non-toxic, injectable hydrogels made of chitosan and hyaluronic acid co-crosslinked with β-glycerophophate and genipin. The gels are highly homogeneous and form within 32 min, i.e., faster than gels crosslinked with either genipin or β-glycerophophate. The shear strength of co-crosslinked hydrogels is 3.5 kPa, higher than any chitosan-based gel reported. Chondrocytes and nucleus pulposus cells thrive inside the gels and produce large amounts of collagen II. Injection in rats shows that the gels form in-vivo within a short time and remain well localized for more than one week while the rats remain healthy and active. The excellent mechanical properties, fast in-situ gelation, good biocompatibility and the ability to encapsulate live cells at physiological conditions make these hydrogels ideal for tissue engineering, especially cartilage regeneration.

Keywords: crosslinking; genipin; hydrogels; in-situ thermogelling; injectable.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cartilage / drug effects*
  • Cartilage / growth & development
  • Chitosan / administration & dosage
  • Chitosan / chemistry
  • Chondrocytes / cytology
  • Chondrocytes / drug effects
  • Collagen / biosynthesis
  • Collagen / drug effects
  • Drug Delivery Systems*
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / chemistry
  • Hydrogels / administration & dosage*
  • Hydrogels / chemistry
  • Iridoids / administration & dosage
  • Iridoids / chemistry
  • Rats
  • Regeneration / drug effects*
  • Tissue Engineering*

Substances

  • Hydrogels
  • Iridoids
  • Hyaluronic Acid
  • Collagen
  • Chitosan
  • genipin